SABS (SAB Biotherapeutics Inc.) Sof foyda

SABS (SAB Biotherapeutics, Inc.) - kompaniyaning tovar belgisi

Yangilangan filtratsiya tizimiga ega bioreaktorlarning barqaror ishlashi SAB Biotherapeutics rivojlanishi uchun asos yaratdi. Bugungi kunda, GURU.Markets xulosalari jadvalida ko'rsatilganidek, kompaniyaning sof foydasi -0.04 miqdorini tashkil etadi, bu esa haqiqiy o'sishni spekulyatsiyadan ajratishga yordam beradi. Kelgusidagi istiqbollar sog'liqni saqlash gigantlari bilan uzoq muddatli ittifoqlar tuzish uchun DiversitAb platformasiga hamda antitanalarning tezlashtirilgan sintezi uchun transgenik sigirlardan foydalanishga tayanadi.

SABS (SAB Biotherapeutics) Sof foyda tarixi 04.07.2022dan 29.10.2026gacha

SAB Biotherapeutics, Inc. (SABS) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari SAB Biotherapeutics Inc|SABS - Tahlilchilar konsensus prognozi
- biznesning bozor baholash ko'rsatkichlari:
Bozor kapitallashuvi SAB Biotherapeutics Inc|SABS - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Aksiyaning buxgalteriya qiymati SAB Biotherapeutics|SABS - Balans kapitallashuvi|Balans qiymatiga nisbatan bozor kapitallashuvi sabbiotherapeutics.com|SABS - Kompaniyaning jami aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati SAB Biotherapeutics|SABS - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati SAB Biotherapeutics Inc.|SABS - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar SAB Biotherapeutics Inc|SABS - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi SAB Biotherapeutics|Shoshilinch likvidlik sabbiotherapeutics.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
SABS - Kompaniyaning sof foydasi
Kompaniyaning jamlanma tahlili:SAB Biotherapeutics
SAB Biotherapeutics, Inc asosiy tovari

Sof foyda, ya'ni -0.04, barcha operatsion va soliq xarajatlari chegirib tashlanganidan keyingi yakuniy moliyaviy natijani aks ettiradi va bu biznesning haqiqiy daromadliligini baholash imkonini beradi. SAB Biotherapeutics (SABS) ning sof foyda tendentsiyalarini tahlil qilish orqali investor SAB Biotherapeutics ning moliyaviy barqarorligini aniqlashi mumkin, bu esa hozirda klinik sinovlar natijalari va antitelolarning qimmatbaho ishlab chiqarilishiga kritik darajada bog'liqdir.

Asosiy raqobatchilar

Sof daromad argenx BVBA|BNTX (BioNTech SE) - Sof foyda|Sof foyda Abivax Pharma|Sof daromad ADMA (ADMA Biologics, Inc.)|PTGX (Protagonist Therapeutics, Inc.) - Yakuniy foyda|Sof foyda IMVT (Immunovant Corp)|Sof moliyaviy natija Kiniksa Corp (KNSA)|GRFS - Kompaniyaning sof foydasi|adaptivebiotech.com (ADPT) - Sof daromad|Celldex Therapeutics, Inc. (CLDX) - Kompaniyaning sof foydasi|Sof daromad Aurinia Pharmaceuticals Inc|Sof daromad BCRX|Sof foyda Vera Corp|Kompaniyaning sof foydasi Dianthus Therapeutics (DNTH)|pharvaris.com - Kompaniya foydasi|Sof foyda ABCL (AbCellera Biologics Inc)|Tourmaline Bio Inc (TRML) - Kompaniyaning sof daromadi|PGEN - Kompaniyaning sof foydasi|Sof moliyaviy natija Pharming Corp PHAR|NKTR: Sof foyda|upstreambio.com (UPB) - Sof foyda|ZBIO (Zenas Biopharma) - Sof foyda|Kompaniyaning sof foydasi IMNM|Sof daromad GOSS (Gossamer Corp)|KALV (KalVista Corp) - Yakuniy foyda|Sof foyda SEPN (Septerna Inc)|pieris.com - Kompaniyaning sof foydasi|Savara - Sof foyda|Sof moliyaviy natija Rigel Pharma RIGL|AnaptysBio Corp (ANAB) - Kompaniyaning sof foydasi|Kompaniyaning sof daromadi Astria Corp (ATXS)|Sof daromad ENGN|RAPT (rapt.com) - Soliqlar to‘langandan keyingi foyda|Sof foyda JBIO|ACRS (Aclaris Therapeutics Inc.) - Yakuniy foyda|Sof foyda KYTX (Kyverna)|Tiziana Life Sciences, Ltd. (TLSA) - Kompaniyaning sof daromadi|CABA - Kompaniyaning sof foydasi|Yakuniy foyda VTYX (ventyxbio.com)|THTX: Sof foyda|Avalo Therapeutics, Inc. (AVTX) - Sof foyda|Kompaniyaning sof foydasi Eledon|Agenus, Inc - Soliqdan keyingi foyda|Sof foyda CLYM|ZURA - Kompaniyaning sof daromadi|aTyr Pharma - Sof daromad|Sof foyda Adagene Inc ADAG|IMA: Sof daromad|Shattuck Labs, Inc. - Soliqlar to‘langandan keyingi foyda|EQ: Sof foyda|CNTB - Sof moliyaviy natija|IMUX (Immunic Therapeutics) - Sof foyda|Sof daromad Atara Biotherapeutics Inc (ATRA)|Kompaniyaning sof foydasi InflaRx N.V. (IFRX)|Sof moliyaviy natija X4 Pharmaceuticals, Inc|Kompaniyaning sof foydasi Adicet Bio, Inc. ACET|Sof moliyaviy natija Celularity Inc (CELU)|INmune Bio - Sof foyda|BRNS - Sof foyda|KZR: Sof foyda|AKTX (Akari Therapeutics, Plc) - Kompaniyaning sof foydasi|Kompaniyaning sof foydasi Enlivex Therapeutics Ltd|Q32 Bio Corp (QTTB) - Sof moliyaviy natija|Kompaniyaning sof foydasi GeoVax (GOVX)|EDSA: Soliqdan keyingi foyda|Sof foyda IBIO (iBio Corp)|Yakuniy foyda CARM|XTL Biopharmaceuticals - Sof foyda|BOLT - Sof foyda|hcwbiologics.com (HCWB) - Kompaniyaning sof foydasi|Aptevo Therapeutics Inc. - Yakuniy foyda|Kompaniyaning sof foydasi AIM ImmunoTech|Sof daromad Aditxt Corp (ADTX)|Sof foyda GRI|Sof foyda xortx.com (XRTX)|Vyome Holdings - Sof daromad|Yakuniy foyda REVB|Indaptus - Sof foyda|Sof moliyaviy natija BiondVax Pharmaceuticals SCNI|calcimedica.com (CALI) - Kompaniyaning sof foydasi|Sof daromad Affimed N.V.|Kompaniyaning sof foydasi Allakos Inc|Sof daromad HOOKIPA (HOOK)|Sof daromad IGMS (IGM Biosciences, Inc.)|Sof foyda iTeos Pharma (ITOS)|Kompaniyaning sof foydasi Ocean Biomedical, Inc. OCEA|TCBP: Kompaniya foydasi|Third Harmonic Bio, Inc. - Sof foyda